Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 227.50
Bid: 227.80
Ask: 228.00
Change: -1.70 (-0.74%)
Spread: 0.20 (0.088%)
Open: 228.80
High: 229.70
Low: 226.20
Prev. Close: 229.20
LGEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

L&G TO SELL L&G NETHERLANDS TO CHESNARA PLC

24 Nov 2016 07:00

RNS Number : 0020Q
Legal & General Group Plc
24 November 2016
 

 

LEGAL & GENERAL TO SELL LEGAL & GENERAL NETHERLANDS TO CHESNARA PLC

Legal & General Group Plc ("Legal & General") has reached agreement in principle with Chesnara plc ("Chesnara") to sell Legal & General Nederland Levensverzekering Maatschappij N.V. ("Legal & General Netherlands") to Chesnara for €160 million. The sale of the business is expected to marginally improve the group coverage ratio, and be for a small IFRS profit.

Mark Gregory, Group Chief Financial Officer, Legal & General said: "Our strategy is focused on having scalable businesses in growth markets. As a consequence, over the last two years, we have disposed of a number of operations we no longer regard as core, including our Irish, French, Egyptian and Gulf businesses, and now we are doing the same with our Dutch business. We have also disposed of the Suffolk Life SIPP business in the UK and agreed a sale of Cofunds."

John Deane, Chief Executive Officer, Chesnara plc said: "Chesnara is delighted to be acquiring another well-run and attractive business in the Dutch life assurance market. As with our Swedish subsidiary Movestic, we will be writing protection and pension policies. This will complement our closed block consolidation business Waard. We see great opportunities for both organisations within the Chesnara group to deliver value to our customers, their advisors and our shareholders."

Legal & General Netherlands' Works Council (ondernemingsraad) has been asked for advice on the transaction, as required under Dutch law. The transaction is subject to the signing of a definitive agreement and the approval of regulatory authorities.

Legal & General Netherlands is headquartered in Hilversum, Netherlands. It was established in 1984, and Pieter Glas has been CEO since April 2016. It is a leading player in adviser-led risk and investment-linked products, sold through independent financial advisers, serving high-end affluent customers. It also has an established defined contribution group pension platform focused on Dutch SMEs. It has over 170,000 policyholders, funds under management are €2.2 billion, and it wrote gross written premiums of £25 million at H1 in 2016.

ends

 

For further information, please contact:

Investors:

Laura Doyle Head of Investor Relations 020 3124 2088

Sujee Rajah Investor Relations Manager 020 3124 2047

 

Media:

Richard King Head of Group Corporate Communications 020 3124 2095

 

 

Financial PR for Chesnara

 

FWD Consulting 020 7280 0651

Roddy Watt 07714 770493

 

Notes to editors:

HSBC acted as exclusive financial advisor to Legal & General.

Legal & General Group Plc:

 

1. Established in 1836, Legal & General is a leading provider of insurance, savings and investment management products in the UK. The Group has a market capitalisation of £14bn (as at 23rd November 2016) and is responsible for investing £841.5bn worldwide (as at 30 June 2016) on behalf of investors, policyholders and shareholders.

2. Legal & General has over seven million customers in the UK for life assurance, pensions, investments and general insurance plans and over one million customers in the US who rely on us for life assurance.

 

3. In 2015, Legal & General's operating profit (IFRS basis) was £1,455m and adjusted earnings per share were 18.58p for the period, an increase of 14% and 11% respectively. For H1 2016 Legal & General's profit before tax was £826m, an increase of 23%, adjusted earnings per share were 11.20p for the period, an increase of 14%, and net cash of £727m, an increase of 16%.

 

For more information on Legal & General, please see http://www.legalandgeneralgroup.com/

 

Forward-looking statements

This announcement may contain certain forward-looking statements relating to Legal & General, its plans and its current goals and expectations relating to future financial condition, performance and results. By their nature, forward-looking statements involve uncertainty because they relate to future events and circumstances which are beyond Legal & General's control, including, among others, UK domestic and global economic and business conditions, market related risks such as fluctuations in interest rates and exchange rates, the policies and actions of regulatory and Governmental authorities, the impact of competition, the timing impact of these events and other uncertainties of future acquisition or combinations within relevant industries. As a result, Legal & General's actual future condition, performance and results may differ materially from the plans, goals and expectations set out in these forward-looking statements and persons reading this announcement should not place reliance on forward-looking statements. These forward-looking statements are made only as at the date on which such statements are made and Legal & General Group Plc does not undertake to update forward-looking statements contained in this announcement or any other forward-looking statement it may make.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISAKNDQKBDBBDB
Date   Source Headline
26th Jun 20246:15 pmRNSTransaction in Own Shares
25th Jun 20246:15 pmRNSTransaction in Own Shares
24th Jun 20246:15 pmRNSTransaction in Own Shares
24th Jun 20246:15 pmRNSDirector/PDMR Shareholding
21st Jun 20246:15 pmRNSTransaction in Own Shares
20th Jun 20246:15 pmRNSDirector/PDMR Shareholding
20th Jun 20246:15 pmRNSTransaction in Own Shares
19th Jun 20246:15 pmRNSTransaction in Own Shares
17th Jun 20246:15 pmRNSTransaction in Own Shares
14th Jun 20246:15 pmRNSTransaction in Own Shares
14th Jun 20246:15 pmRNSDirector/PDMR Shareholding
13th Jun 20246:15 pmRNSTransaction in Own Shares
13th Jun 20247:00 amRNSCommencement of Share Buyback
12th Jun 20247:00 amRNSLegal & General Group plc Capital Markets Event
10th Jun 20245:00 pmRNSDirector/PDMR Shareholding
7th Jun 20245:30 pmRNSDirector/PDMR Shareholding
7th Jun 20245:30 pmRNSDirector/PDMR Shareholding
4th Jun 20245:00 pmRNSDirector/PDMR Shareholding
4th Jun 20245:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20245:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20245:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20245:00 pmRNSTotal Voting Rights
23rd May 20243:00 pmRNSResult of AGM
16th May 20245:00 pmRNSDirector/PDMR Shareholding
13th May 20245:00 pmRNSDirector/PDMR Shareholding
7th May 20245:00 pmRNSDirector Declaration
2nd May 20245:00 pmRNSDirector/PDMR Shareholding
1st May 20245:22 pmRNSTotal Voting Rights
1st May 20245:22 pmRNSDirector/PDMR Shareholding
1st May 20245:20 pmRNSDirector/PDMR Shareholding
18th Apr 20245:00 pmRNSDirector/PDMR Shareholding
17th Apr 20245:00 pmRNSDirector/PDMR Shareholding
11th Apr 20243:00 pmRNSPublication of a Prospectus
11th Apr 202410:00 amRNSNotice of AGM
9th Apr 20245:07 pmRNSDirector/PDMR Shareholding
3rd Apr 20245:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:00 pmRNSTotal Voting Rights
21st Mar 20249:00 amRNSDirector/PDMR Shareholding
13th Mar 202410:30 amRNSAnnual Financial Report
6th Mar 20247:00 amRNSL&G Full Year Results 2023 Part 2
6th Mar 20247:00 amRNSL&G Full Year Results 2023 Part 1
4th Mar 20245:00 pmRNSDirector/PDMR Shareholding
1st Mar 20245:00 pmRNSDirector/PDMR Shareholding
1st Mar 20245:00 pmRNSDirector/PDMR Shareholding
1st Mar 20245:00 pmRNSTotal Voting Rights
27th Feb 20249:00 amRNSChange of Group Remuneration Committee Chair
23rd Feb 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.